T cell responses to human endogenous retroviruses in HIV-1 infection.
Human endogenous retroviruses (HERVs) are remnants of ancient infectious agents that have integrated into the human genome. Under normal circumstances, HERVs are functionally defective or controlled by host factors. In HIV-1-infected individuals, intracellular defense mechanisms are compromised. We...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2007
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a8303acd1f5b468b9a449226feeb4925 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a8303acd1f5b468b9a449226feeb4925 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a8303acd1f5b468b9a449226feeb49252021-11-25T05:46:20ZT cell responses to human endogenous retroviruses in HIV-1 infection.1553-73661553-737410.1371/journal.ppat.0030165https://doaj.org/article/a8303acd1f5b468b9a449226feeb49252007-11-01T00:00:00Zhttps://doi.org/10.1371/journal.ppat.0030165https://doaj.org/toc/1553-7366https://doaj.org/toc/1553-7374Human endogenous retroviruses (HERVs) are remnants of ancient infectious agents that have integrated into the human genome. Under normal circumstances, HERVs are functionally defective or controlled by host factors. In HIV-1-infected individuals, intracellular defense mechanisms are compromised. We hypothesized that HIV-1 infection would remove or alter controls on HERV activity. Expression of HERV could potentially stimulate a T cell response to HERV antigens, and in regions of HIV-1/HERV similarity, these T cells could be cross-reactive. We determined that the levels of HERV production in HIV-1-positive individuals exceed those of HIV-1-negative controls. To investigate the impact of HERV activity on specific immunity, we examined T cell responses to HERV peptides in 29 HIV-1-positive and 13 HIV-1-negative study participants. We report T cell responses to peptides derived from regions of HERV detected by ELISPOT analysis in the HIV-1-positive study participants. We show an inverse correlation between anti-HERV T cell responses and HIV-1 plasma viral load. In HIV-1-positive individuals, we demonstrate that HERV-specific T cells are capable of killing cells presenting their cognate peptide. These data indicate that HIV-1 infection leads to HERV expression and stimulation of a HERV-specific CD8+ T cell response. HERV-specific CD8+ T cells have characteristics consistent with an important role in the response to HIV-1 infection: a phenotype similar to that of T cells responding to an effectively controlled virus (cytomegalovirus), an inverse correlation with HIV-1 plasma viral load, and the ability to lyse cells presenting their target peptide. These characteristics suggest that elicitation of anti-HERV-specific immune responses is a novel approach to immunotherapeutic vaccination. As endogenous retroviral sequences are fixed in the human genome, they provide a stable target, and HERV-specific T cells could recognize a cell infected by any HIV-1 viral variant. HERV-specific immunity is an important new avenue for investigation in HIV-1 pathogenesis and vaccine design.Keith E GarrisonR Brad JonesDuncan A MeiklejohnNaveed AnwarLishomwa C NdhlovuJoan M ChapmanAnn L EricksonAshish AgrawalGerald SpottsFrederick M HechtSeth Rakoff-NahoumJack LenzMario A OstrowskiDouglas F NixonPublic Library of Science (PLoS)articleImmunologic diseases. AllergyRC581-607Biology (General)QH301-705.5ENPLoS Pathogens, Vol 3, Iss 11, p e165 (2007) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 |
spellingShingle |
Immunologic diseases. Allergy RC581-607 Biology (General) QH301-705.5 Keith E Garrison R Brad Jones Duncan A Meiklejohn Naveed Anwar Lishomwa C Ndhlovu Joan M Chapman Ann L Erickson Ashish Agrawal Gerald Spotts Frederick M Hecht Seth Rakoff-Nahoum Jack Lenz Mario A Ostrowski Douglas F Nixon T cell responses to human endogenous retroviruses in HIV-1 infection. |
description |
Human endogenous retroviruses (HERVs) are remnants of ancient infectious agents that have integrated into the human genome. Under normal circumstances, HERVs are functionally defective or controlled by host factors. In HIV-1-infected individuals, intracellular defense mechanisms are compromised. We hypothesized that HIV-1 infection would remove or alter controls on HERV activity. Expression of HERV could potentially stimulate a T cell response to HERV antigens, and in regions of HIV-1/HERV similarity, these T cells could be cross-reactive. We determined that the levels of HERV production in HIV-1-positive individuals exceed those of HIV-1-negative controls. To investigate the impact of HERV activity on specific immunity, we examined T cell responses to HERV peptides in 29 HIV-1-positive and 13 HIV-1-negative study participants. We report T cell responses to peptides derived from regions of HERV detected by ELISPOT analysis in the HIV-1-positive study participants. We show an inverse correlation between anti-HERV T cell responses and HIV-1 plasma viral load. In HIV-1-positive individuals, we demonstrate that HERV-specific T cells are capable of killing cells presenting their cognate peptide. These data indicate that HIV-1 infection leads to HERV expression and stimulation of a HERV-specific CD8+ T cell response. HERV-specific CD8+ T cells have characteristics consistent with an important role in the response to HIV-1 infection: a phenotype similar to that of T cells responding to an effectively controlled virus (cytomegalovirus), an inverse correlation with HIV-1 plasma viral load, and the ability to lyse cells presenting their target peptide. These characteristics suggest that elicitation of anti-HERV-specific immune responses is a novel approach to immunotherapeutic vaccination. As endogenous retroviral sequences are fixed in the human genome, they provide a stable target, and HERV-specific T cells could recognize a cell infected by any HIV-1 viral variant. HERV-specific immunity is an important new avenue for investigation in HIV-1 pathogenesis and vaccine design. |
format |
article |
author |
Keith E Garrison R Brad Jones Duncan A Meiklejohn Naveed Anwar Lishomwa C Ndhlovu Joan M Chapman Ann L Erickson Ashish Agrawal Gerald Spotts Frederick M Hecht Seth Rakoff-Nahoum Jack Lenz Mario A Ostrowski Douglas F Nixon |
author_facet |
Keith E Garrison R Brad Jones Duncan A Meiklejohn Naveed Anwar Lishomwa C Ndhlovu Joan M Chapman Ann L Erickson Ashish Agrawal Gerald Spotts Frederick M Hecht Seth Rakoff-Nahoum Jack Lenz Mario A Ostrowski Douglas F Nixon |
author_sort |
Keith E Garrison |
title |
T cell responses to human endogenous retroviruses in HIV-1 infection. |
title_short |
T cell responses to human endogenous retroviruses in HIV-1 infection. |
title_full |
T cell responses to human endogenous retroviruses in HIV-1 infection. |
title_fullStr |
T cell responses to human endogenous retroviruses in HIV-1 infection. |
title_full_unstemmed |
T cell responses to human endogenous retroviruses in HIV-1 infection. |
title_sort |
t cell responses to human endogenous retroviruses in hiv-1 infection. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2007 |
url |
https://doaj.org/article/a8303acd1f5b468b9a449226feeb4925 |
work_keys_str_mv |
AT keithegarrison tcellresponsestohumanendogenousretrovirusesinhiv1infection AT rbradjones tcellresponsestohumanendogenousretrovirusesinhiv1infection AT duncanameiklejohn tcellresponsestohumanendogenousretrovirusesinhiv1infection AT naveedanwar tcellresponsestohumanendogenousretrovirusesinhiv1infection AT lishomwacndhlovu tcellresponsestohumanendogenousretrovirusesinhiv1infection AT joanmchapman tcellresponsestohumanendogenousretrovirusesinhiv1infection AT annlerickson tcellresponsestohumanendogenousretrovirusesinhiv1infection AT ashishagrawal tcellresponsestohumanendogenousretrovirusesinhiv1infection AT geraldspotts tcellresponsestohumanendogenousretrovirusesinhiv1infection AT frederickmhecht tcellresponsestohumanendogenousretrovirusesinhiv1infection AT sethrakoffnahoum tcellresponsestohumanendogenousretrovirusesinhiv1infection AT jacklenz tcellresponsestohumanendogenousretrovirusesinhiv1infection AT marioaostrowski tcellresponsestohumanendogenousretrovirusesinhiv1infection AT douglasfnixon tcellresponsestohumanendogenousretrovirusesinhiv1infection |
_version_ |
1718414475856445440 |